We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to sudden death. The clinical trial will investigate whether rapamycin can reduce the life-threatening heart remodelling associated with SAS. It is hoped our novel therapy may reduce disease severity and improve outcomes and quality of life for dogs with this devastating disease.
To read more: https://maf.link/SAS22